Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...
MicrobiomicsEHU group of the University of the Basque Country explains fungal influence on the development of melanoma cells ...
A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results